Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$173M |
| 2 |
Amcor
AMCR
|
+$138M |
| 3 |
Microsoft
MSFT
|
+$99.3M |
| 4 |
Amazon
AMZN
|
+$97.5M |
| 5 |
Intel
INTC
|
+$96.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$126M |
| 2 |
Alexandria Real Estate Equities
ARE
|
+$123M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$58.6M |
| 4 |
IDTI
Integrated Device Technology I
IDTI
|
+$45.7M |
| 5 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$44.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.86% |
| 2 | Financials | 14.49% |
| 3 | Healthcare | 12.78% |
| 4 | Industrials | 10.5% |
| 5 | Consumer Discretionary | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYBX
2976
DELISTED
Synlogic
SYBX
| $339K | ﹤0.01% |
2,481
+248
| +11% | +$30.2K |
|
|
FCCY
2977
DELISTED
1st Constitution Bancorp
FCCY
| $336K | ﹤0.01% |
18,177
| – | – |
|
2978
Astrana Health
ASTH
$1.86B
| $332K | ﹤0.01% |
19,822
+6,816
| +52% | +$124K |
|
2979
Oak Valley Bancorp
OVLY
$279M
| $331K | ﹤0.01% |
16,895
+1,267
| +8% | +$24.3K |
|
|
AMRS
2980
DELISTED
Amyris Inc.
AMRS
| $330K | ﹤0.01% |
92,549
+24,252
| +36% | +$95.5K |
|
|
PRGX
2981
DELISTED
PRGX Global, Inc.
PRGX
| $329K | ﹤0.01% |
48,956
| – | – |
|
2982
KALA BIO
KALA
$14.6M
| $328K | ﹤0.01% |
21
+6
| +40% | +$99.4K |
|
|
CALA
2983
DELISTED
Calithera Biosciences, Inc
CALA
| $327K | ﹤0.01% |
4,192
+327
| +8% | +$37.1K |
|
|
ROAN
2984
DELISTED
Roan Resources, Inc.
ROAN
| $326K | ﹤0.01% |
186,865
+59,039
| +46% | +$213K |
|
|
SRT
2985
DELISTED
Startek Inc.
SRT
| $324K | ﹤0.01% |
+39,602
| New | +$303K |
|
2986
Airgain
AIRG
$71.7M
| $321K | ﹤0.01% |
+22,662
| New | +$327K |
|
|
YARW
2987
Yarrow Bioscience, Inc. Common Stock
YARW
$112M
| $321K | ﹤0.01% |
15
+4
| +36% | +$99K |
|
2988
Peoples Bancorp of North Carolina
PEBK
$228M
| $318K | ﹤0.01% |
10,577
| – | – |
|
2989
X4 Pharmaceuticals
XFOR
$421M
| $317K | ﹤0.01% |
+703
| New | +$357K |
|
|
ZVO
2990
DELISTED
Zovio Inc. Common Stock
ZVO
| $317K | ﹤0.01% |
88,442
-7,651
| -8% | -$38.1K |
|
2991
Ponce Financial Group
PDLB
$484M
| $316K | ﹤0.01% |
30,792
+2,384
| +8% | +$24.3K |
|
2992
Galectin Therapeutics
GALT
$315M
| $312K | ﹤0.01% |
+75,092
| New | +$325K |
|
2993
Verrica Pharmaceuticals
VRCA
$88M
| $312K | ﹤0.01% |
2,681
+73
| +3% | +$6.85K |
|
|
PAMT
2994
PAMT Corp
PAMT
$287M
| $311K | ﹤0.01% |
20,028
| – | – |
|
2995
XBiotech
XBIT
$69.5M
| $309K | ﹤0.01% |
+40,732
| New | +$354K |
|
2996
Colony Bankcorp
CBAN
$465M
| $308K | ﹤0.01% |
+18,143
| New | +$309K |
|
2997
Smart Sand
SND
$197M
| $308K | ﹤0.01% |
126,161
-14,776
| -10% | -$52.4K |
|
|
FNCB
2998
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $308K | ﹤0.01% |
+39,720
| New | +$306K |
|
2999
Escalade
ESCA
$294M
| $305K | ﹤0.01% |
26,551
+2,196
| +9% | +$25.4K |
|
3000
Global Water Resources
GWRS
$212M
| $305K | ﹤0.01% |
29,151
+2,757
| +10% | +$27.1K |
|
Similar funds
Charles Schwab's Q2 2019 Portfolio in Review
As of Q2 2019, Charles Schwab held 3,341 positions worth $164B, up 5.3% from $156B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Charles Schwab's Q2 2019 filing shows 147 new, 2,302 increased, 628 reduced and 129 closed positions. Its largest new stake was Dow Inc: 3,280,629 shares worth $162M. The largest sale was DuPont de Nemours, an estimated $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2019 buy was Dow Inc: 3,280,629 shares worth $162M.
- Charles Schwab added most to Microsoft in Q2 2019, an estimated $99.3M increase.
- Charles Schwab's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $126M.
- Charles Schwab fully exited China Mobile Limited in Q2 2019, selling an estimated $58.6M.
- Charles Schwab's ten largest holdings make up 15% of its $164B portfolio in Q2 2019.
- Charles Schwab opened 147 new positions and closed 129 in Q2 2019.
- Charles Schwab's portfolio value rose 5.3% quarter-over-quarter to $164B.
Based on Charles Schwab's 13F filing for Q2 2019, filed 9 Aug 2019.